Education
About Us
Working with TipRanks
Follow Us
Alkem Laboratories Ltd. (IN:ALKEM)
:ALKEM
RESEARCH TOOLSreports
Total Valuation
Alkem Laboratories Ltd. has a market cap or net worth of ₹624.25B. The enterprise value is ―.
Market Cap₹624.25B
Enterprise Value―
Share Statistics
Alkem Laboratories Ltd. has 119,565,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding119,565,000
Owned by Insiders―
Owned by Institutions0.02%
Financial Efficiency
Alkem Laboratories Ltd.’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 13.92%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)13.92%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.81
Inventory Turnover2.79
Valuation Ratios
The current PE Ratio of Alkem Laboratories Ltd. is 33.35. Alkem Laboratories Ltd.’s PEG ratio is 18.66.
PE Ratio33.35
PS Ratio0.00
PB Ratio5.08
Price to Fair Value5.81
Price to FCF419.84
Price to Operating Cash Flow419.85
PEG Ratio18.66
Income Statement
In the last 12 months, Alkem Laboratories Ltd. had revenue of 125.67B and earned 17.96B in profits. Earnings per share was 150.19.
Revenue125.67B
Gross Profit51.29B
Operating Income19.85B
Pretax Income20.23B
Net Income17.96B
EBITDA24.20B
Earnings Per Share (EPS)150.19
Cash Flow
In the last 12 months, operating cash flow was 2.87B and capital expenditures 0.00, giving a free cash flow of 2.87B billion.
Operating Cash Flow2.87B
Free Cash Flow2.87B
Free Cash Flow per Share24.00
Dividends & Yields
Alkem Laboratories Ltd. pays an annual dividend of ₹37, resulting in a dividend yield of 0.8%
Dividend Per Share₹37
Dividend Yield0.8%
Payout Ratio2.78%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-1.18%
50-Day Moving Average4.93K
200-Day Moving Average5.39K
Relative Strength Index (RSI)61.27
Average Volume (3m)1.55K
Important Dates
Alkem Laboratories Ltd. upcoming earnings date is May 29, 2025, TBA Not Confirmed.
Last Earnings DateFeb 7, 2025
Next Earnings DateMay 29, 2025
Ex-Dividend DateFeb 14, 2025
Financial Position
Alkem Laboratories Ltd. as a current ratio of 2.61, with Debt / Equity ratio of 12.86%
Current Ratio2.61
Quick Ratio1.94
Debt to Market Cap0.02
Net Debt to EBITDA0.40
Interest Coverage Ratio17.66
Taxes
In the past 12 months, Alkem Laboratories Ltd. has paid 2.12B in taxes.
Income Tax2.12B
Effective Tax Rate0.10
Enterprise Valuation
Alkem Laboratories Ltd. EV to EBITDA ratio is 25.15, with an EV/FCF ratio of 36.03.
EV to Sales4.84
EV to EBITDA25.15
EV to Free Cash Flow36.03
EV to Operating Cash Flow31.24
Balance Sheet
Alkem Laboratories Ltd. has ₹42.70B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹42.70B billion.
Cash & Marketable Securities₹42.70B
Total Debt₹0.00
Net Cash-₹42.70B
Net Cash Per Share-₹357.10
Tangible Book Value Per Share₹856.44
Margins
Gross margin is 54.03%, with operating margin of 15.79%, and net profit margin of 14.29%.
Gross Margin54.03%
Operating Margin15.79%
Pretax Margin16.10%
Net Profit Margin14.29%
EBITDA Margin19.25%
EBIT Margin16.86%
Analyst Forecast
The average price target for Alkem Laboratories Ltd. is ₹5,461.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹5,461.00
Price Target Upside15.60% Upside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast―